Kharisa Rachmasari (@kharisa_rachma) 's Twitter Profile
Kharisa Rachmasari

@kharisa_rachma

Mayo Clinic Endocrinology Fellow #thyroidnerd 💛🇮🇩

ID: 2214481520

calendar_today25-11-2013 18:20:42

9 Tweet

41 Followers

35 Following

David Toro Tobon (@davidtorot) 's Twitter Profile Photo

Significant improvement in proptosis and severity with Teprotumumab in steroid naive patients with thyroid eye disease. @kharisa_01 sharing the Mayo Clinic Endocrinology experience.

Significant improvement in proptosis and severity with Teprotumumab in steroid naive patients with thyroid eye disease. @kharisa_01 sharing the <a href="/MayoClinicEndo/">Mayo Clinic Endocrinology</a> experience.
David Toro Tobon (@davidtorot) 's Twitter Profile Photo

In patients with steroid-resistant TED: 1. Teprotumumab significantly improves proptosis, severity and CAS, and 2. Tocilizumab improves the inflammatory features Sharing the Mayo Clinic Endocrinology experience on TED at #ATA2022 American Thyroid Association #Thyroid #Endotwitter

In patients with steroid-resistant TED: 1. Teprotumumab significantly improves proptosis, severity and CAS, and 2. Tocilizumab improves the inflammatory features

Sharing the <a href="/MayoClinicEndo/">Mayo Clinic Endocrinology</a> experience on TED at #ATA2022

<a href="/AmThyroidAssn/">American Thyroid Association</a> #Thyroid #Endotwitter